menu
{ "item_title" : "The Timing of Toxicological Studies to Support Clinical Trials", "item_author" : [" C. Parkinson", "N. McAuslane", "C. Lumley "], "item_description" : "Over the past twelve years, the Centre for Medicines Research has held a series of Workshops on a number of topics related to the drug discovery and development process. The major objective of these Workshops has been to provide an international forum for regula- tory, academic and industry representatives to debate together, and suggest solutions to, specific problems. The meeting reported in this volume represents a departure from this approach, in that the par- ticipants were drawn largely from the pharmaceutical industry. Senior clinicians, pharmacologists and toxicologists from companies in Europe, the USA and Japan met in May 1994 to discuss a scientific rationale for the conduct of toxicity studies to support the clinical development of new medicines, and to begin to work towards an industry consensus. Achievement of such a consensus is seen as an important step in the process leading towards international harmon- isation of the recommendations on the timing of toxicity studies in relation to clinical trials.", "item_img_path" : "https://covers2.booksamillion.com/covers/bam/9/40/104/623/9401046239_b.jpg", "price_data" : { "retail_price" : "109.99", "online_price" : "109.99", "our_price" : "109.99", "club_price" : "109.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
The Timing of Toxicological Studies to Support Clinical Trials|C. Parkinson

The Timing of Toxicological Studies to Support Clinical Trials

local_shippingShip to Me
In Stock.
FREE Shipping for Club Members help

Overview

Over the past twelve years, the Centre for Medicines Research has held a series of Workshops on a number of topics related to the drug discovery and development process. The major objective of these Workshops has been to provide an international forum for regula- tory, academic and industry representatives to debate together, and suggest solutions to, specific problems. The meeting reported in this volume represents a departure from this approach, in that the par- ticipants were drawn largely from the pharmaceutical industry. Senior clinicians, pharmacologists and toxicologists from companies in Europe, the USA and Japan met in May 1994 to discuss a scientific rationale for the conduct of toxicity studies to support the clinical development of new medicines, and to begin to work towards an industry consensus. Achievement of such a consensus is seen as an important step in the process leading towards international harmon- isation of the recommendations on the timing of toxicity studies in relation to clinical trials.

This item is Non-Returnable

Details

  • ISBN-13: 9789401046237
  • ISBN-10: 9401046239
  • Publisher: Springer
  • Publish Date: September 2012
  • Dimensions: 9.21 x 6.14 x 0.37 inches
  • Shipping Weight: 0.55 pounds
  • Page Count: 150

Related Categories

You May Also Like...

    1

BAM Customer Reviews